Return to content in this issue
Successful Subcutaneous Desensitization to Certolizumab Pegol
Peñalver MJ, Bautista-Villanueva S, Barranco R, Crespo JF, Mielgo R
Allergy Department, Hospital Universitario 12 de Octubre, Madrid, Spain
J Investig Allergol Clin Immunol 2024; Vol 34(4)
: 272-274
doi: 10.18176/jiaci.0981
Key words: TNFα inhibitor, Certolizumab, Hypersensitivity, Desensitization, Allergy